A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction
Background. Fat grafting is a tremendous tool in secondary breast reconstruction. Stromal vascular fraction (SVF) enriched fat grafts have been presenting promising results regarding volume maintenance. Methods. We developed a method that produces a superior SVF enrichment rate (2 : 1) in the operat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/2636454 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564138052681728 |
|---|---|
| author | L. A. L. Tissiani N. Alonso |
| author_facet | L. A. L. Tissiani N. Alonso |
| author_sort | L. A. L. Tissiani |
| collection | DOAJ |
| description | Background. Fat grafting is a tremendous tool in secondary breast reconstruction. Stromal vascular fraction (SVF) enriched fat grafts have been presenting promising results regarding volume maintenance. Methods. We developed a method that produces a superior SVF enrichment rate (2 : 1) in the operating theatre. This prospective and controlled trial analyzed quantitatively and qualitatively fat grafts with (stem cells group, SG) and without (control group, CG) SVF enrichment in secondary breast reconstruction, through MRI-based volumetry, immunophenotyping, and cell counting. Also, patient satisfaction, aesthetic outcomes, and complications were analyzed. Results. Volumetric persistence in the SG was 78,9% and 51,4% in the CG; however it did not reach statistical significant difference. CD90 was the only marker highly expressed in the SG and showed a positive correlation with volumetric persistence (r=0.651, p=0.03). Fat necrosis occurred in 4 patients in the SG and in none in the CG. Patients in the CG showed a trend to be more satisfied. Considering aesthetics, both groups presented improvements. No locoregional recurrences were observed. Conclusions. Results are encouraging despite the fact that SVF enrichment in a higher supplementation rate did not improve, with statistical significance, fat graft volumetric persistence. Enriched fat grafts have proven to be safe in a 3-year follow-up. |
| format | Article |
| id | doaj-art-a7e7a7da495b4943adeefc1136e25b30 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-a7e7a7da495b4943adeefc1136e25b302025-02-03T01:11:39ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/26364542636454A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast ReconstructionL. A. L. Tissiani0N. Alonso1Department of Plastic Surgery, Medical School, University of São Paulo, 04516-010 São Paulo, SP, BrazilDepartment of Plastic Surgery, Medical School, University of São Paulo, 04516-010 São Paulo, SP, BrazilBackground. Fat grafting is a tremendous tool in secondary breast reconstruction. Stromal vascular fraction (SVF) enriched fat grafts have been presenting promising results regarding volume maintenance. Methods. We developed a method that produces a superior SVF enrichment rate (2 : 1) in the operating theatre. This prospective and controlled trial analyzed quantitatively and qualitatively fat grafts with (stem cells group, SG) and without (control group, CG) SVF enrichment in secondary breast reconstruction, through MRI-based volumetry, immunophenotyping, and cell counting. Also, patient satisfaction, aesthetic outcomes, and complications were analyzed. Results. Volumetric persistence in the SG was 78,9% and 51,4% in the CG; however it did not reach statistical significant difference. CD90 was the only marker highly expressed in the SG and showed a positive correlation with volumetric persistence (r=0.651, p=0.03). Fat necrosis occurred in 4 patients in the SG and in none in the CG. Patients in the CG showed a trend to be more satisfied. Considering aesthetics, both groups presented improvements. No locoregional recurrences were observed. Conclusions. Results are encouraging despite the fact that SVF enrichment in a higher supplementation rate did not improve, with statistical significance, fat graft volumetric persistence. Enriched fat grafts have proven to be safe in a 3-year follow-up.http://dx.doi.org/10.1155/2016/2636454 |
| spellingShingle | L. A. L. Tissiani N. Alonso A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction Stem Cells International |
| title | A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction |
| title_full | A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction |
| title_fullStr | A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction |
| title_full_unstemmed | A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction |
| title_short | A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction |
| title_sort | prospective and controlled clinical trial on stromal vascular fraction enriched fat grafts in secondary breast reconstruction |
| url | http://dx.doi.org/10.1155/2016/2636454 |
| work_keys_str_mv | AT laltissiani aprospectiveandcontrolledclinicaltrialonstromalvascularfractionenrichedfatgraftsinsecondarybreastreconstruction AT nalonso aprospectiveandcontrolledclinicaltrialonstromalvascularfractionenrichedfatgraftsinsecondarybreastreconstruction AT laltissiani prospectiveandcontrolledclinicaltrialonstromalvascularfractionenrichedfatgraftsinsecondarybreastreconstruction AT nalonso prospectiveandcontrolledclinicaltrialonstromalvascularfractionenrichedfatgraftsinsecondarybreastreconstruction |